ArticleImpact of a Pharmacist ICS Deprescribing Intervention on COPD Exacerbations and Adverse EventsAuthor:Steffanie Danley, PharmD, BPACP, BCPS Publish date: June 30, 2026Chronic obstructive pulmonary disease (COPD) affects about 25% of the veteran population and is the third-leading cause of death globally. Read More
